## Abstract Since the amount of hepatitis C virus (HCV) RNA might be correlated with the degree of severity of hepatitis and response to treatment, quantitation of HCV RNA in serum was established using competitive polymerase chain reaction (PCR). Known amounts of a plasmid containing HCVβcDNA were
Homogeneous Quantitative Assay of Hepatitis C Virus RNA by Polymerase Chain Reaction in the Presence of a Fluorescent Intercalater
β Scribed by T. Ishiguro; J. Saitoh; H. Yawata; H. Yamagishi; S. Iwasaki; Y. Mitoma
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 564 KB
- Volume
- 229
- Category
- Article
- ISSN
- 0003-2697
No coin nor oath required. For personal study only.
β¦ Synopsis
We have developed a homogeneous quantitative assay of DNA/RNA by performing PCR in the presence of an oxazole yellow derivative, a fluorescent DNA intercalative dye, and monitoring the fluorescence intensity of the PCR reaction mixture during PCR cycles. We have demonstrated the applicability of this assay by use it to quantify hepatitis C virus (HCV) RNA of serum samples from patients with chronic hepatitis C. This assay gave efficient and reproducible results in a clinically useful dynamic range below (10^{-6}) copies of HCV RNA for interferon therapy. 1995 Academic Press, Inc.
π SIMILAR VOLUMES
## Abstract The mean prevalence of antiβhepatitis C virus (HCV) in Italy is 0.87%. It reaches 2% in Campania, Southern Italy. Approximately 50% of community acquired nonβA, nonβB (NANB) hepatitis cannot be associated with known parenteral exposure. A recent Italian study has shown that the only dem
## Abstract The low specificity of screening ELISAs for antibodies to hepatitis C virus in blood donors has called for confirmatory tests. Two types of supplementary antibody assays are available, recombinant immunoblot assays (RIBAβ1 and RIBAβ2) and an antibody consumption test referred to as a ne
Three PCR methods based on the GB virus-C/ hepatitis G virus (GBV-C/HGV) 5ΠUTR and NS3 genomic region were used for the detection of GBV-C/HGV RNA in serum of 62 patients with chronic hepatitis C virus (HCV) infection. Ten of 62 (16%) patients were found to have GBV-C/ HGV RNA, which was confirmed b
Eq/mL, P Γ΅ .01). There was no difference in the pre-Hepatitis C virus (HCV) replicates at a low rate, treatment proportion of HCV RNA -positive hepatoand this makes its detection and intrahepatic localcytes among patients with different biochemical reization difficult. To evaluate the clinical impli